AmacaThera, Pacira Sign $230M Global Licensing Deal
AmacaThera, a leading developer of next generation hydrogel-based drug delivery solutions that enable precise, tunable, and sustained release to improve a wide range of active therapeutics,...
Category : Healthcare and Pharmaceutical
Moberg, Karo Ink EU License Deal for MOB-015/Terclara
Moberg Pharma AB (publ) has entered into an exclusive licensing agreement with Karo Healthcare AB regarding the commercialization of MOB-015 (Terclara®) in Europe. The agreement...
Abzena, Mabqi Partner on Integrated Drug Development
Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, and Mabqi, a biotechnology company focused on the discovery and development of fully human...
Amber Implants Names Vincent Gardès as New CEO
Amber Implants, an innovative medical technology company developing next-generation implants for spinal injuries, today announced the appointment of Vincent Gardès as Chief Executive Officer, effective...
SkylineDx Wins 2025 BioTech Award for Diagnostics Company
SkylineDx, an innovative diagnostics company specializing in the research and development of molecular diagnostics for oncology, and inflammatory and infectious diseases, today announced it has...
Shield CRC Blood Test Shows 95% Adherence in 20,000 Patients
Published study adds to growing evidence that the Shield blood-based screening test boosts adherence Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today...
Watchmaker Genomics Launches TAPS+ to Boost Oncology Capabilities
– TAPS+ enables simultaneous detection of methylation and genetic variants, unlocking new insights for precision oncology and translational research.– Preserves DNA integrity in challenging clinically relevant samples,...
Merz Aesthetics Expands Ultherapy PRIME for Arms and Abdomen
Latest Intention for USE Expands to Improve the Appearance of Skin Laxity on the Posterior and Anterior Arms and Abdomen, to launch in the United States...
Magnet Biomedicine Appoints Bharat Reddy as Chief Business Officer
Dr. Reddy brings more than ten years of experience leading biopharma development and strategy to Magnet’s leadership Magnet Biomedicine, a leading biopharmaceutical company advancing molecular...
Ratio Therapeutics Names Marcel Reichen as Chief Strategy Officer
Ratio Therapeutics Inc. (Ratio), a pharmaceutical company employing innovative technologies to develop best-in-class radiopharmaceuticals for cancer treatment and monitoring, today announced the appointment of Marcel...
Azenta Life Sciences Partners with PRECEDE on Pancreatic Cancer
Azenta, Inc. (Nasdaq: AZTA) today announced a strategic partnership with the PRECEDE Foundation, an international, multi-institutional collaborative focused on early detection and prevention of pancreatic cancer....
Eilean Therapeutics Shows TE205 Efficacy in Ulcerative Colitis
Eilean Therapeutics LLC, a biopharmaceutical company dedicated to developing best-in-class and first-in-class small-molecule therapies targeting genetic escape mutations in cancer and advancing innovative treatments for...
Delphi Diagnostics to Present Endocrine Activity Index at SABCS
Delphi Diagnostics announces the upcoming presentation of four scientific abstracts, including one platform presentation highlighting new clinical data supporting the company’s innovative breast cancer diagnostic...
Braveheart Bio Raises $185M Series A to Transform HCM Care
Leadership brings experience in company building, advancing late-stage clinical programs, and deep understanding of cardiovascular drug development Company intends to rapidly advance BHB-1893 into late-stage clinical...
Health In Tech Announces Davos 2026 Panel on Women Who Build
Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, today announced an expansion of its agenda for the Independent InsurTech Summit...